<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;B02B&quot;,&quot;href&quot;:&quot;atc/B02B.md&quot;},{&quot;label&quot;:&quot;eltrombopag&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;Eltrombopag_Farrell2014_reference&quot;,&quot;label&quot;:&quot;Farrell_2014_reference&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_eltrombopag/Eltrombopag_Farrell2014_reference.md&quot;,&quot;status&quot;:&quot;extracted \u00b7 stale&quot;,&quot;css&quot;:&quot;pk-badge--green&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Eltrombopag_Gibiansky2011_reference&quot;,&quot;label&quot;:&quot;Gibiansky_2011_reference&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_eltrombopag/Eltrombopag_Gibiansky2011_reference.md&quot;,&quot;status&quot;:&quot;extracted \u00b7 stale&quot;,&quot;css&quot;:&quot;pk-badge--green&quot;,&quot;here&quot;:false}]"></div>

# eltrombopag

- **generic name:** eltrombopag
- **ATC codes:** `B02BX05`
- **DrugBank:** [DB06210](https://go.drugbank.com/drugs/DB06210) · **PubChem:** [CID 9846180](https://pubchem.ncbi.nlm.nih.gov/compound/9846180)
- **molar mass:** 442.4666 g/mol (C25H22N4O4) — DrugBank
- **groups:** approved, investigational

## About

Eltrombopag is a medicine used to raise low platelet counts in conditions such as immune thrombocytopenic purpura and aplastic anemia. It is an approved drug authorised in the European Union, where it is used for these platelet disorders.

<small>Summary written by `glm-5.3-flash` from [Wikidata Q411588](https://www.wikidata.org/wiki/Q411588) and the WHO ATC classification and the EMA medicines list; not checked by a person.</small>

## Molecules and molar masses

> The molar mass each model uses to convert mass to molar concentration and to form a metabolite molecule for molecule. Looked up, never estimated: DrugBank for the drug, the paper's own value or the PubChem entry matched to the paper's name for a metabolite.

| molecule | role | molar mass (g/mol) | formula | source | PubChem | records |
|---|---|---|---|---|---|---|
| eltrombopag | parent | 442.467 | C25H22N4O4 | DrugBank | [9846180](https://pubchem.ncbi.nlm.nih.gov/compound/9846180) | Farrell_2014, Gibiansky_2011, Saleh_2019 |

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-05 18:44 | 10:20 | 2/1/0 | 4/0/1 | 0/0/0 | 115,350/35,303 | ollama / qwen3.8:27b-mtp-q8_0 | 1 | 1/0 | 1/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--green">extracted</span> <span class="pk-badge pk-badge--stale">stale</span> <span class="pk-badge pk-badge--orange" title="re-read by gpt-oss:120b (partly confirmed, agreement 0.75). The first reading is what the record holds.">cross-check: partial</span><br><sub>STALE — current validate: extracted</sub><br><sub>route_to: `engineer_replication`</sub> | [Farrell_2014_reference](drugs/drug_eltrombopag/Eltrombopag_Farrell2014_reference.md) | ▶ model + simulator | 2-compartment, oral | 7 | Farrell C et al., Population pharmacokinetic/pharmacodyna…, British journal of clinical… (2014) | [10.1111/bcp.12244](https://doi.org/10.1111/bcp.12244) |
| <span class="pk-badge pk-badge--green">extracted</span> <span class="pk-badge pk-badge--stale">stale</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.167). The first reading is what the record holds.">cross-check: disputed</span><br><sub>STALE — current validate: extracted</sub><br><sub>route_to: `engineer_replication`</sub> | [Gibiansky_2011_reference](drugs/drug_eltrombopag/Eltrombopag_Gibiansky2011_reference.md) | ▶ model + simulator | 2-compartment, oral | 4 | Gibiansky E et al., Population pharmacokinetics of eltrombo…, Journal of clinical pharmac… (2011) | [10.1177/0091270010375427](https://doi.org/10.1177/0091270010375427) |
| <span class="pk-badge pk-badge--red">rejected</span> <span class="pk-badge pk-badge--stale">stale</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.182). The first reading is what the record holds.">cross-check: disputed</span><br><sub>STALE — current validate: rejected</sub><br><sub>blocking: C8 unreachable/orphan compartment or unlinked metabolite</sub><br><sub>route_to: `human_review`</sub> | [Saleh_2019_reference](drugs/drug_eltrombopag/Eltrombopag_Saleh2019_reference.md) | — | 1-compartment (no model) | 3 | Saleh MI et al., Bayesian Population Pharmacokinetic Mod…, European journal of drug me… (2019) | [10.1007/s13318-018-0490-x](https://doi.org/10.1007/s13318-018-0490-x) |

## Pharmacodynamics (PD)

| status | detail | about | model | citation | doi |
|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--green">extracted</span> | [Hayes_2011_PLTC](drugs/drug_eltrombopag/pd_Hayes_2011_PLTC.md) | platelet counts ← eltrombopag · direct linear effect | — | Hayes S et al., Population PK/PD modeling of eltrombopa…, Journal of clinical pharmac… (2011) | [10.1177/0091270010383019](https://doi.org/10.1177/0091270010383019) |
| <span class="pk-badge pk-badge--green">extracted</span> | [Hayes_2013_PLT](drugs/drug_eltrombopag/pd_Hayes_2013_PLT.md) | platelet counts ← eltrombopag · indirect response — drug stimulates the production of platelet counts | — | Hayes S et al., Population PK/PD modeling of eltrombopa…, Cancer chemotherapy and pha… (2013) | [10.1007/s00280-013-2150-9](https://doi.org/10.1007/s00280-013-2150-9) |
| <span class="pk-badge pk-badge--green">extracted</span> | [Wu_2015_PLTC](drugs/drug_eltrombopag/pd_Wu_2015_PLTC.md) | platelet count ← eltrombopag · delayed effect through transit (transduction) compartments | — | Wu K et al., Population Pharmacokinetic and Pharmaco…, Clinical therapeutics (2015) | [10.1016/j.clinthera.2015.03.024](https://doi.org/10.1016/j.clinthera.2015.03.024) |
| <span class="pk-badge pk-badge--green">extracted</span> | [Zhang_2015_PLT](drugs/drug_eltrombopag/pd_Zhang_2015_PLT.md) | platelet counts ← eltrombopag · indirect response — drug stimulates the production of platelet counts | — | Zhang J et al., Modeling and simulation support eltromb…, Pharmaceutical research (2015) | [10.1007/s11095-014-1594-x](https://doi.org/10.1007/s11095-014-1594-x) |
| <span class="pk-badge pk-badge--orange">needs review</span> | [Farrell_2014_PLT](drugs/drug_eltrombopag/pd_Farrell_2014_PLT.md) | platelet count ← eltrombopag · indirect response — drug stimulates the production of platelet count | — | Farrell C et al., Population pharmacokinetic/pharmacodyna…, British journal of clinical… (2014) | [10.1111/bcp.12244](https://doi.org/10.1111/bcp.12244) |

## ADME sites

Where this drug is handled, from DrugBank's curated enzymes / transporters / carriers and the KB's PGx genes, mapped to tissue through the ADME gene table. Compare it with other drugs on the [Sites & interactions](sites?drugs=eltrombopag) page (add drugs there; the set becomes a link).

| process | tissue | actors (role) | evidence |
|---|---|---|---|
| absorption | blood-brain barrier | `ABCG2` inhibitor | DrugBank actor |
| absorption | liver | `ABCG2` inhibitor | DrugBank actor |
| absorption | mammary gland | `ABCG2` inhibitor | DrugBank actor |
| absorption | small intestine | `ABCG2` inhibitor | DrugBank actor |
| absorption | testis | `ABCG2` inhibitor | DrugBank actor |
| metabolism | kidney | `UGT1A9` inhibitor | DrugBank actor |
| metabolism | liver | `CYP1A2` substrate, `CYP2C8` inhibitor/substrate, `SLCO1B1` inhibitor, `UGT1A1` inhibitor/substrate, `UGT1A3` substrate, `UGT1A9` inhibitor | DrugBank actor |
| metabolism | small intestine | `UGT1A1` inhibitor/substrate | DrugBank actor |
| excretion | bile duct | <sub>named in DrugBank's ADME text</sub> | prose |
| excretion | kidney | <sub>named in DrugBank's ADME text</sub> | prose |

<sub>Actors without a tissue in the table: MPL (target).</sub>

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>the data come from an animal (or in-vitro) study, not from people. The record, its model and its simulation are kept — they describe that species.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 18 matched, 17 returned
- **screened:** 3  ·  **relevant:** 3
- **records:** 3  ·  extracted 2  ·  needs_review 0  ·  rejected 1  ·  stale 3
- **scholar-agent fallback query used:** not captured

## Full text wanted

_8 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Gibiansky_2011.pdf` | Gibiansky E et al., Population pharmacokinetics of eltrombo…, Journal of clinical pharmac… (2011) | popPK | 10 | [10.1177/0091270010375427](https://doi.org/10.1177/0091270010375427) | [20663993](https://pubmed.ncbi.nlm.nih.gov/20663993) | The paper reports a population PK model for eltrombopag with explicit numeric values for CL/F, Vc/F, Vp/F, and Q/F in the abstract. |
| `Hayes_2011.pdf` | Hayes S et al., Population PK/PD modeling of eltrombopa…, Journal of clinical pharmac… (2011) | popPK | 10 | [10.1177/0091270010383019](https://doi.org/10.1177/0091270010383019) | [21148042](https://pubmed.ncbi.nlm.nih.gov/21148042) | The paper describes a population PK/PD model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| `Hayes_2013.pdf` | Hayes S et al., Population PK/PD modeling of eltrombopa…, Cancer chemotherapy and pha… (2013) | popPK | 10 | [10.1007/s00280-013-2150-9](https://doi.org/10.1007/s00280-013-2150-9) | [23564375](https://pubmed.ncbi.nlm.nih.gov/23564375) | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence. |
| `Saleh_2019.pdf` | Saleh MI et al., Bayesian Population Pharmacokinetic Mod…, European journal of drug me… (2019) | popPK | 10 | [10.1007/s13318-018-0490-x](https://doi.org/10.1007/s13318-018-0490-x) | [29948848](https://pubmed.ncbi.nlm.nih.gov/29948848) | The paper reports a population PK model for eltrombopag with specific numeric values for clearance, volume of distribution, and absorption parameters in the abstract. |
| `Wire_2018.pdf` | Wire MB et al., Modeling and Simulation Support Eltromb…, Clinical pharmacology and t… (2018) | popPK | 10 | [10.1002/cpt.1066](https://doi.org/10.1002/cpt.1066) | [29536526](https://pubmed.ncbi.nlm.nih.gov/29536526) | The paper describes a population PK/PD model for eltrombopag in pediatric patients, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| `Wu_2015.pdf` | Wu K et al., Population Pharmacokinetic and Pharmaco…, Clinical therapeutics (2015) | popPK | 10 | [10.1016/j.clinthera.2015.03.024](https://doi.org/10.1016/j.clinthera.2015.03.024) | [25929594](https://pubmed.ncbi.nlm.nih.gov/25929594) | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| `Zhang_2015.pdf` | Zhang J et al., Modeling and simulation support eltromb…, Pharmaceutical research (2015) | popPK | 10 | [10.1007/s11095-014-1594-x](https://doi.org/10.1007/s11095-014-1594-x) | [25534682](https://pubmed.ncbi.nlm.nih.gov/25534682) | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence. |
| `Zhang_2024.pdf` | Zhang W et al., Efficacy, Safety, and Population Pharma…, Journal of clinical pharmac… (2024) | popPK | 10 | [10.1002/jcph.2430](https://doi.org/10.1002/jcph.2430) | [38497347](https://pubmed.ncbi.nlm.nih.gov/38497347) | The paper describes a population pharmacokinetic model for eltrombopag in children, but the specific numeric parameter values (CL/F, V/F) are not present in the provided abstract text. |

<sub>queue written 2026-10-05T18:34:20.612781+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Hayes_2011 | relevant | 10 | 0 | The paper describes a population PK/PD model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| popPK | Hayes_2013 | relevant | 10 | 0 | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence. |
| popPK | Wire_2018 | relevant | 10 | 0 | The paper describes a population PK/PD model for eltrombopag in pediatric patients, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| popPK | Wu_2015 | relevant | 10 | 0 | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided abstract text. |
| popPK | Zhang_2015 | relevant | 10 | 0 | The paper describes a population PK model for eltrombopag, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence. |
| popPK | Zhang_2024 | relevant | 10 | 2 | The paper describes a population pharmacokinetic model for eltrombopag in children, but the specific numeric parameter values (CL/F, V/F) are not present in the provided abstract text. |
| popPK | van_2023 | irrelevant | 0 | 0 | The study evaluates hemostatic and coagulation parameters (platelet function, thrombin generation) rather than pharmacokinetic disposition parameters for eltrombopag. |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-10-05 18:34 UTC</sub>
